We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
-1.54%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$96.4B
AUM Growth
-$1.4B
(-1.4%)
Cap. Flow
+$1.2B
Cap. Flow
% of AUM
1.25%
Top 10 Holdings %
Top 10 Hldgs %
33.93%
Holding
280
New
10
Increased
138
Reduced
66
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$363M |
| 2 |
JPMorgan Chase
JPM
|
+$363M |
| 3 |
American Airlines Group
AAL
|
+$310M |
| 4 |
CarMax
KMX
|
+$258M |
| 5 |
FedEx
FDX
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$779M |
| 2 |
DYAX
DYAX CORPORATION
DYAX
|
+$394M |
| 3 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$213M |
| 4 |
Bath & Body Works
BBWI
|
+$134M |
| 5 |
GSK
GSK
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.64% |
| 2 | Healthcare | 23.79% |
| 3 | Industrials | 15.28% |
| 4 | Consumer Discretionary | 9.12% |
| 5 | Financials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Newell Brands
NWL
$2.56B
| $34.5M | 0.04% |
778,060
+90,000
| +13% | +$3.53M |
|
177
Standard BioTools
LAB
$314M
| $34.4M | 0.04% |
4,266,432
| – | – |
|
|
GRMN
178
Garmin
GRMN
$60B
| $33.6M | 0.03% |
841,500
+92,000
| +12% | +$3.42M |
|
|
CAM
179
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $32.2M | 0.03% |
480,200
| – | – |
|
180
Stryker
SYK
$130B
| $31.7M | 0.03% |
295,500
| – | – |
|
|
DD
181
DELISTED
Du Pont De Nemours E I
DD
| $30.5M | 0.03% |
482,200
-1,600
| -0.3% | -$95.8K |
|
|
EXAS
182
DELISTED
Exact Sciences
EXAS
| $30.4M | 0.03% |
4,516,300
+1,420,000
| +46% | +$9.08M |
|
|
HA
183
DELISTED
Hawaiian Holdings, Inc.
HA
| $29.9M | 0.03% |
634,500
| – | – |
|
|
RKUS
184
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
| $29.3M | 0.03% |
2,989,732
+1,446,329
| +94% | +$13.4M |
|
|
TPCO
185
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $27.6M | 0.03% |
3,570,968
-173,175
| -5% | -$1.4M |
|
186
McDonald's
MCD
$195B
| $26.7M | 0.03% |
+212,700
| New | +$25.4M |
|
187
Teradyne
TER
$59.3B
| $26.1M | 0.03% |
1,209,000
+150,000
| +14% | +$2.93M |
|
188
Whirlpool
WHR
$2.82B
| $25.5M | 0.03% |
141,600
-190,000
| -57% | -$28.3M |
|
|
MNTA
189
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $25.3M | 0.03% |
2,738,900
| – | – |
|
|
BUFF
190
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
| $25.2M | 0.03% |
982,400
+35,834
| +4% | +$688K |
|
191
Salesforce
CRM
$158B
| $24.6M | 0.03% |
332,860
+15,400
| +5% | +$1.06M |
|
|
SZYM
192
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
| $24.5M | 0.03% |
12,057,284
-5,800
| -0% | -$10.3K |
|
193
Hilton Worldwide
HLT
$71.5B
| $24.4M | 0.03% |
360,933
+206,266
| +133% | +$12.3M |
|
|
PFNX
194
DELISTED
Pfenex Inc.
PFNX
| $23.9M | 0.02% |
2,431,388
| – | – |
|
195
HubSpot
HUBS
$10.5B
| $22.5M | 0.02% |
+515,000
| New | +$22.1M |
|
|
DBD
196
DELISTED
Diebold Nixdorf Incorporated
DBD
| $22.1M | 0.02% |
766,000
+115,000
| +18% | +$3.01M |
|
197
Marriott International
MAR
$92.3B
| $21.4M | 0.02% |
300,000
+180,000
| +150% | +$11.8M |
|
198
Comcast
CMCSA
$90B
| $21M | 0.02% |
687,934
+301,934
| +78% | +$8.67M |
|
|
GUID
199
DELISTED
Guidance Software, Inc.
GUID
| $19.7M | 0.02% |
4,585,315
| – | – |
|
200
Republic Services
RSG
$66B
| $18.7M | 0.02% |
392,935
+9,000
| +2% | +$408K |
|
Similar funds
VAM
Primecap Management's Q1 2016 Portfolio in Review
As of Q1 2016, Primecap Management held 280 positions worth $96.4B, down 1.4% from $97.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Primecap Management's Q1 2016 filing shows 10 new, 138 increased, 66 reduced and 10 closed positions. Its largest new stake was Northern Trust: 1,775,400 shares worth $116M. The largest sale was Johnson & Johnson, an estimated $779M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2016 buy was Northern Trust: 1,775,400 shares worth $116M.
- Primecap Management added most to AstraZeneca in Q1 2016, an estimated $363M increase.
- Primecap Management's biggest Q1 2016 reduction was Johnson & Johnson, cutting an estimated $779M.
- Primecap Management fully exited DYAX CORPORATION in Q1 2016, selling an estimated $394M.
- Primecap Management's ten largest holdings make up 34% of its $96.4B portfolio in Q1 2016.
- Primecap Management opened 10 new positions and closed 10 in Q1 2016.
- Primecap Management's portfolio value fell 1.4% quarter-over-quarter to $96.4B.
Based on Primecap Management's 13F filing for Q1 2016, filed 12 May 2016.